ESC 365 - An atrial fibrillation patient needing combination antiarrhythmic drug treatment

Back

ESC Premium Access

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - Conclusion and take home message.

Session: Atrial fibrillation: from Guidelines to clinical practice

Topic: Atrial Fibrillation (AF)

Speaker: Professor N. Marrouche (New Orleans, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Nassir Marrouche

Tulane University, New Orleans (United States of America)

29 presentations

1 follower

7 more presentations in this session

Case 1: an atrial fibrillation patient needing combination antiarrhythmic drug treatment

Speaker: Professor G. Dan (Bucharest, RO)

Access

Slides

Video

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - What do the Guidelines say?

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access

Slides

Video

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - How to implement the Guidelines.

Access

Slides

Video

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Speaker: Doctor M. Akao (Kyoto, JP)

Access

Slides

Video

An atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment - What do the Guidelines say?

Speaker: Professor M. Taborsky (Olomouc, CZ)

Access

Slides

Video

Access the full session

Atrial fibrillation: from Guidelines to clinical practice

Speakers: Professor N. Marrouche, Professor G. Dan, Professor P. Kirchhof, Doctor M. Akao, Professor M. Taborsky

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources